Purpose: To use and test a labeling algorithm that operates on two-dimensional reformations, rather than three-dimensional data to locate and identify vertebrae.
Materials And Methods: The authors improved the Btrfly Net, a fully convolutional network architecture described by Sekuboyina et al, which works on sagittal and coronal maximum intensity projections (MIPs) and augmented it with two additional components: spine localization and adversarial a priori learning. Furthermore, two variants of adversarial training schemes that incorporated the anatomic a priori knowledge into the Btrfly Net were explored. The superiority of the proposed approach for labeling vertebrae on three datasets was investigated: a public benchmarking dataset of 302 CT scans and two in-house datasets with a total of 238 CT scans. The Wilcoxon signed rank test was employed to compute the statistical significance of the improvement in performance observed with various architectural components in the authors' approach.
Results: On the public dataset, the authors' approach using the described Btrfly Net with energy-based prior encoding (Btrfly) network performed as well as current state-of-the-art methods, achieving a statistically significant ( < .001) vertebrae identification rate of 88.5% ± 0.2 (standard deviation) and localization distances of less than 7 mm. On the in-house datasets that had a higher interscan data variability, an identification rate of 85.1% ± 1.2 was obtained.
Conclusion: An identification performance comparable to existing three-dimensional approaches was achieved when labeling vertebrae on two-dimensional MIPs. The performance was further improved using the proposed adversarial training regimen that effectively enforced local spine a priori knowledge during training. Spine localization increased the generalizability of our approach by homogenizing the content in the MIPs.© RSNA, 2020.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017405 | PMC |
http://dx.doi.org/10.1148/ryai.2020190074 | DOI Listing |
Alzheimers Dement
December 2024
UNC Chapel Hill, Chapel Hill, NC, USA.
Background: In the last decade, we have demonstrated that the brain-enriched E3 ubiquitin ligase TRIM9 regulates cytoskeletal dynamics, membrane remodeling, and netrin-dependent signaling pathways in all stages of neuron development, including the maturation of dendritic spines and electrophysiological activity. Moreover, TRIM9 protein levels increase in the adult brain and are maintained throughout adulthood. In the adult mouse TRIM9 is enriched within the postsynaptic density (PSD), a proteinaceous rich region in the post synapse, containing neurotransmitter receptors, scaffolding proteins, and cytoskeletal elements.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Yale University, New Haven, CT, USA.
Background: Advances in Alzheimer's disease (AD) have revealed a novel fluid biomarker, tau phosphorylated at T217 (pT217-tau), in CSF and plasma, that predicts AD prior to cognitive deficits. Understanding the role of pT217-tau is important in assessing efficacy of novel treatments aimed at early-stage disease. However, it is unknown why pT217-tau is effective in predicting brain pathology, as little is known about early, soluble pT217-tau brain expression.
View Article and Find Full Text PDFBrain Behav
January 2025
Department of Surgery, Medical College, King Faisal University, Hofuf, Ahsa, Saudi Arabia.
Background: Duloxetine, a serotonin and norepinephrine reuptake inhibitor (SNRI), is used to treat various health conditions, including major depressive disorder, generalized anxiety disorder, fibromyalgia, and off-label for chemotherapy-induced pain. We conducted this systematic review and meta-analysis aiming to test the current evidence regarding effectiveness and safety of duloxetine for postspine surgeries pain.
Methods: We searched the Cochrane Central Register of Controlled Trials, PubMed, Scopus and Web of science databases for relevant articles up to March 2024.
Bio Protoc
December 2024
Division of Life Science, Graduate School of Science and Engineering, Saitama University, Shimo-Okubo 255, Sakura-ku, Saitama, Japan.
Zebrafish and medaka are valuable model vertebrates for genetic studies. The advent of CRISPR-Cas9 technology has greatly enhanced our capability to produce specific gene mutants in zebrafish and medaka. Analyzing the phenotypes of these mutants is essential for elucidating gene function, though such analyses often yield unexpected results.
View Article and Find Full Text PDFLancet Digit Health
January 2025
Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA. Electronic address:
Background: Palliative spine radiation therapy is prone to treatment at the wrong anatomic level. We developed a fully automated deep learning-based spine-targeting quality assurance system (DL-SpiQA) for detecting treatment at the wrong anatomic level. DL-SpiQA was evaluated based on retrospective testing of spine radiation therapy treatments and prospective clinical deployment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!